Richard Flavell studies how immune cells recognize threats, differentiate, and maintain tolerance at Yale and HHMI. A scientific founder of Santa Ana Bio and Ventus Therapeutics, he connects molecular immunology with new approaches to inflammatory disease.
Richard Flavell studies how immune cells recognize threats, differentiate, and maintain tolerance at Yale and HHMI. A scientific founder of Santa Ana Bio and Ventus Therapeutics, he connects molecular immunology with new approaches to inflammatory disease.
Career
VTScientific Founder at Ventus Therapeutics from 2020 to Present
YUSterling Professor of Immunobiology at Yale University until Present
HHInvestigator at Howard Hughes Medical Institute until Present
Scientific Founder at Santa Ana Bio until PresentBRPresident and Chief Scientific Officer at Biogen Research Corporation from 1982 to 1988
NIHead, Laboratory of Gene Structure and Expression at National Institute for Medical Research from 1979 to 1982
UOAssistant Professor at University of Amsterdam from 1974 to 1979
